Perfumes as urease inhibitors

By using fragrances with molecular weights of 95 to 225 g/mol as urease inhibitors, the problem of ammonia odor formation in consumer products is solved, effective urease inhibition and the provision of various fragrances is achieved, suitable for personal, household and pet care products.

CN118922068APending Publication Date: 2024-11-08SYMRISE GMBH & CO KG
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202280093716.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-03-22
Filing Date
2022-04-20
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The prior art is difficult to effectively prevent the formation of ammonia odor in consumer products, especially due to the lack of safety and cost in traditional urease inhibitors, and it is difficult to apply in fragrances.

Method used

The fragrances with molecular weights of 95 to 225 g/mol were developed as urease inhibitors, which can effectively inhibit the activity of bacterial urease, thereby reducing the formation of ammonia. These fragrances are easy to obtain, colorless, odorless, have high stability and are for humans. Non-toxic and can be combined with other flavors to provide a variety of fragrances.

Benefits of technology

It achieves effective inhibition of urease activity at low concentrations and reduces the formation of ammonia. It is suitable for personal care products, home care products and pet care products, providing a cost-effective and safe solution that can be combined with other fragrances to produce a variety of fragrances .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005044551630000021
    Figure BDA0005044551630000021
  • Figure BDA0005044551630000041
    Figure BDA0005044551630000041
  • Figure BDA0005044551630000051
    Figure BDA0005044551630000051
Patent Text Reader

Abstract

The invention relates to the use of at least one perfume having a molecular weight between 95 and 225 g / mol as a urease inhibitor.
Need to check novelty before this filing date? Find Prior Art

Description

Field of the Invention

[0001] The present invention relates to the field of functional fragrances, in particular to preventing the formation of ammonia odor, and more particularly to fragrances with the ability to inhibit urease. Background of the Invention

[0002] Fragrance products such as perfumes, deodorants or other fragrance-containing personal care products, home care products, pet care products or cosmetics have been widely used to mask unpleasant odors. However, overcoming ammonia malodor is a major challenge because it not only activates the olfactory system, but also triggers the trigeminal chemosensory sensation. The latter is well known as a warning system for exposure to chemical hazards (in this case due to changes in pH), so this sensation is very unpleasant and difficult to mask with traditional fragrances. Therefore, the best way to eliminate ammonia odor is to prevent it from forming.

[0003] The most prevalent form of ammonia formation in living systems and the environment is the enzymatic degradation of urea by bacterial ureases. Therefore, one can use antimicrobials to reduce the number of urease-positive bacteria or inhibit urease by chemical methods to prevent the formation of ammonia.

[0004] Urease inhibition has been thoroughly studied from a medical perspective, but also for agricultural products, especially urea-containing fertilizers. In both fields, very powerful small molecule inhibitors have been developed that are highly specific and effective against urease. Unfortunately, these compounds are not suitable for use in consumer products for a variety of reasons, such as safety and cost aspects.

[0005] It is therefore an object of the present invention to provide a cost-effective, safe and fragrance-compatible urease inhibitor which can be easily used in consumer products to address the challenge of ammonia malodor formation. Summary of the invention

[0006] According to the invention, there is provided at least one fragrance having a molecular weight of 95 to 225 g / mol for use as urease inhibitor, in particular as urease inhibitors.

[0007] The present inventors have surprisingly found that fragrances having a molecular weight between 95 and 225 g / mol inhibit the activity of urease, in particular bacterial urease, thereby reducing the amount of ammonia produced from ammonia precursors, such as urea.

[0008] Ureases functionally belong to the superfamily of amidohydrolases and phosphotriesterases. Ureases are found in many bacteria, fungi, algae, plants and some invertebrates as well as in soil as soil enzymes. They are high molecular weight nickel-containing metalloenzymes. These enzymes catalyze the hydrolysis of urea into carbon dioxide and ammonia: The hydrolysis of urea occurs in two stages. In the first stage, ammonia and carbamate are produced. Carbamate is spontaneously and rapidly hydrolyzed into ammonia and carbonic acid. Urease activity increases the pH of its environment as alkaline ammonia is produced.

[0009] Furthermore, the fragrances used according to the invention are advantageously easily available or readily available or easy to prepare, are very effective even at low concentrations, in particular at concentrations where the fragrance has no or barely perceptible odor, are almost or completely colorless, have a high stability in various mixtures or preparations, and have no toxic and / or allergic effects on humans.

[0010] The spices of the present invention also have the advantage that they can be combined with different spices and fragrance oils or common components of fragrance oils other than the spices of the present invention so that any desired spices can be used to perfume the product. Therefore, by the present invention, a variety of fragrance types can be provided to consumers.

[0011] "Urease inhibitors" or "urease inhibitors" according to the invention are compounds, in particular fragrances, which reduce or completely prevent the activity of urease.

[0012] In a preferred embodiment according to the invention, the amount of at least one fragrance when added to the composition or product is insufficient to impart an intrinsic odor thereto. The fragrances according to the invention have the advantage that when used, in particular for the use according to the invention, they are already active for the purposes of the invention at low concentrations without odor or at least without imparting a perceptible intrinsic odor. This allows these fragrances to be combined with different fragrances (not according to the invention) and optionally other components of the fragrance oil to produce particularly advantageous fragrance mixtures or other fragrance products with any desired odor.

[0013] In a preferred embodiment according to the invention, the composition or product is a consumer product. A "consumer product" according to the invention is a product purchased by an individual or family for personal use. In other words, a consumer product is a commodity purchased by an ordinary consumer for consumption. Preferred consumer products according to the invention are personal care products, in particular toilet care products, in particular perfume and / or fragrance compositions, household care products, pet care products, in particular cat litter and cosmetics.

[0014] In a preferred embodiment according to the present invention, at least one fragrance is selected from fragrances with a molecular weight of 95 to 225 g / mol, in particular alcohols, carbonyl compounds, aldehydes, ketones, ethers and esters. More preferably, at least one fragrance is selected from fragrances with a molecular weight of 95 to 225 g / mol, in particular α,β-unsaturated carbonyl compounds, β-unsaturated alcohols and γ-unsaturated esters.

[0015] In another preferred embodiment according to the present invention, the at least one fragrance is selected from the group consisting of cis-1-(1-ethoxyethoxy)-3-hexene (geraniol acetal), 3,7-dimethyl-2,6-octadien-1-ol (mixed or separated isomers; geraniol), trans-2-hexenol, cis-3-hexenol, trans-2-hexenal, 3,7-dimethyloct-2,6-dienal (Citral FF), cis-3-hexenyl butyrate, (E)-1-(2,6,6-trimethyl-1-cyclohexa-1,3-dienyl)but-2-ene-1-one (Damascenone total), (E)-1-(2,6,6-trimethyl-1-cyclohex-2-enyl)but-2-ene-1-one (Damascone total). alpha), cis-3-hexenyl propionate, cis-3-hexenyl acetate, cis-3-hexenyl hexanoate, cis-3-hexenyl isovalerate, cis-3-hexenyl isobutyrate, (2E)-3-phenylprop-2-en-1-ol (cinnamyl alcohol), α-methylcinnamaldehyde, cis-3-hexenyl salicylate, 4-hydroxy-2,5-dimethyl-3-furanone (Furaneol), methylcyclopentenolone-3,2,2, methylethylhydroxyfuranone, 2-ethoxy-4-methylphenol (Ultravanil), 2-methoxyphenol (guaiacol), 2-methoxy-4-(prop-2-en-1-yl)phenol (eugenol), 3-(1,3-benzodiphenylamine) Helional, Furaminton / Tonkalactone TM ), (2Z)-3,7-dimethylocta-2,6-dien-1-ol (Nerol 900), 2,6-nonadien-1-ol, methylionone α, methylionone γ, or a mixture thereof.

[0016] In a more preferred embodiment according to the present invention, the at least one fragrance is selected from the group consisting of salicylic acid cis-3-hexenyl ester, cis-1-(1-ethoxyethoxy)-3-hexene (leaf alcohol acetal), trans-2-hexenal, methyl ethyl hydroxy furanone, butyric acid cis-3-hexenyl ester or a mixture thereof. More preferably, the at least one fragrance is selected from trans-2-hexenal and / or methyl ethyl hydroxy furanone. Most preferably, the at least one fragrance is selected from trans-2-hexenal.

[0017] In another preferred embodiment, at least one fragrance is selected from the group consisting of 3,7-dimethyl-2,6-octadien-1-ol (mixed or separated isomers; geraniol) and / or 3,7-dimethylocta-2,6-dienal (Citral FF).

[0018] In other words, in another preferred embodiment according to the present invention, at least one fragrance is selected from the following group:

[0019] In another embodiment according to the present invention, when added to a composition or product, the at least one fragrance is used in an amount of 0.01 to 10% by weight, based on the total weight of the composition or product. More preferably, the at least one fragrance is used in an amount of 0.05 to 5% by weight; more preferably, it is used in an amount of 0.05 to 1% by weight, and most preferably, it is used in an amount of 0.05 to 0.5% by weight; all weight percentages are based on the total weight of the composition or product.

[0020] Particularly advantageous is the use according to the invention in which the ratio of the total mass of the at least one fragrance to the total mass of the at least one ammonia precursor is from 1:1 to 1:5, more preferably from 1:2 to 1:4.

[0021] A "precursor" according to the present invention is a compound that participates in a chemical reaction that produces another compound. In the present case, an "ammonia precursor" is a compound that participates in a chemical reaction that produces ammonia. In one embodiment according to the present invention, the ammonia precursor is urea.

[0022] Therefore, in a preferred embodiment according to the invention, the at least one fragrance is used together with at least one ammonia precursor as a urease inhibitor in a composition or product, in particular a consumer product. Thus, when in contact with, for example, bacterial urease, the formation of ammonia can be completely but at least partially prevented by the fragrance according to the invention.

[0023] It goes without saying that one or more fragrances with a molecular weight between 95 and 225 g / mol can be used to inhibit urease activity. Thus, for example, one, two, three, four, five, six, seven, eight, nine, ten fragrances with a molecular weight between 95 and 225 g / mol can be used to inhibit urease activity in consumer products.

[0024] Examples of other fragrances which can in principle be advantageously used as further components together with at least one fragrance according to the invention having a molecular weight of between 95 and 225 g / mol can be found, for example, in S. Arctander, Perfume and Flavor Chemicals, Vol. I and II, Montclair, NJ, 1969, Selbstverlag oder H. Surburg, J. Panten, Common Fragrance and Flavor Materials, 5th Ed., Wiley-VCH, Weinheim 2006.

[0025] Another embodiment of the present invention relates to a consumer product comprising (a) a fragrance composition comprising at least one fragrance having a molecular weight between 95 and 225 g / mol as a urease inhibitor; and (b) at least one ammonia precursor.

[0026] As already explained above, fragrances having a molecular weight between 95 and 225 g / mol inhibit the activity of urease, in particular bacterial urease, thereby reducing the amount of ammonia produced from ammonia precursors, such as urea.

[0027] In a preferred embodiment according to the present invention, the consumer product further comprises (c) at least one emulsifier selected from the group consisting of cetearyl ethylhexanoate, cetearyl alcohol, potassium cetyl phosphate, sodium cetyl sulfate, PEG-40 stearate.

[0028] In a preferred embodiment according to the present invention, the consumer product does not contain any other urease inhibitor. As mentioned above, preferred consumer products according to the present invention are personal care products, in particular toilet care products, in particular perfume and / or fragrance compositions, household care products, pet care products, in particular cat litter and cosmetics.

[0029] Preferably, the at least one fragrance is present in an amount of 0.01 to 10% by weight, based on the total weight of the consumer product. More preferably, the at least one fragrance is present in an amount of 0.05 to 5% by weight, based on the total weight of the consumer product. Even more preferably, the at least one fragrance is present in an amount of 0.05 to 1% by weight, based on the total weight of the consumer product.

[0030] In a preferred embodiment, the ratio of the at least one fragrance having a molecular weight between 95 and 225 g / mol to the at least one ammonia precursor is from 1:1 to 1:5, more preferably from 1:2 to 1:4.

[0031] In another preferred embodiment according to the present invention, the at least one fragrance is selected from the following group: cis-1-(1-ethoxyethoxy)-3-hexene (leaf alcohol acetal), 3,7-dimethyl-2,6-octadien-1-ol (mixed or separated isomers; geraniol), trans-2-hexenol, cis-3-hexenol, trans-2-hexenal, 3,7-dimethyloct-2,6-dienal (Citral FF), cis-3-hexenyl butyrate, (E)-1-(2,6,6-trimethyl-1-cyclohexa-1,3-dienyl)but-2-ene-1-one (Damascenone total), (E)-1-(2,6,6-trimethyl-1-cyclohex-2-enyl)but-2-ene-1-one (Damascone total). alpha), cis-3-hexenyl propionate, cis-3-hexenyl acetate, cis-3-hexenyl hexanoate, cis-3-hexenyl isovalerate, cis-3-hexenyl isobutyrate, (2E)-3-phenylprop-2-en-1-ol (cinnamyl alcohol), α-methylcinnamaldehyde, cis-3-hexenyl salicylate, 4-hydroxy-2,5-dimethyl-3-furanone (Furaneol), methylcyclopentenolone-3,2,2, methylethylhydroxyfuranone, 2-ethoxy-4-methylphenol (Ultravanil), 2-methoxyphenol (guaiacol), 2-methoxy-4-(prop-2-en-1-yl)phenol (eugenol), 3-(1,3-benzodiphenylamine) Helional, Furaminton / Tonkalactone TM ), (2Z)-3,7-dimethylocta-2,6-dien-1-ol (Nerol 900), 2,6-nonadien-1-ol, methylionone α, methylionone γ, or a mixture thereof.

[0032] In a more preferred embodiment according to the present invention, the at least one fragrance is selected from the group consisting of salicylic acid cis-3-hexenyl ester, cis-1-(1-ethoxyethoxy)-3-hexene (leaf alcohol acetal), trans-2-hexenal, methyl ethyl hydroxy furanone, butyric acid cis-3-hexenyl ester or a mixture thereof. More preferably, at least one fragrance is selected from trans-2-hexenal and / or methyl ethyl hydroxy furanone. Most preferably, at least one fragrance is selected from trans-2-hexenal.

[0033] In another preferred embodiment, the at least one fragrance is selected from the group consisting of 3,7-dimethyl-2,6-octadien-1-ol (mixed or separated isomers; geraniol) and / or 3,7-dimethylocta-2,6-dienal (Citral FF).

[0034] The fragrance composition according to the invention, which contains at least one fragrance having a molecular weight between 95 and 225 g / mol, can be in liquid form, undiluted or diluted with a solvent, and is advantageously used for perfumery. Preferred solvents for this purpose are ethanol, isopropanol, diethylene glycol monoethyl ether, glycerol, propylene glycol, 1,2-butylene glycol, dipropylene glycol, diethyl phthalate, triethyl citrate, isopropyl myristate, triacetin and diacetin.

[0035] Furthermore, the fragrance composition according to the invention can be adsorbed on a carrier which allows both fine distribution of the fragrance in the product and controlled release during application. Such a carrier can be a porous inorganic material, such as light sulfate, silica gel, zeolite, gypsum, clay, clay particles, aerated concrete, etc., or an organic material, such as wood, cellulose-based materials, sugar, dextrin (e.g. maltodextrin) or plastic, such as PVC, polyvinyl acetate or polyurethane. The final combination of the composition according to the invention and the carrier is also to be understood as a fragrance composition according to the invention, or can be present as a product according to the invention (as further described herein).

[0036] The fragrance composition according to the invention can also be microencapsulated, spray-dried, as inclusion compound or as extruded product and can be added in this form, for example, to the product to be perfumed.

[0037] If desired, the properties of the composition can be further optimized by so-called "coating" with suitable materials for a more targeted release of the fragrance, preferably using waxy plastics such as polyvinyl alcohol.

[0038] The other preferred embodiments and definitions that have been described above of course also apply to the consumer product according to the invention.

[0039] Another embodiment of the present invention relates to a method of inhibiting urease activity in a composition or product, wherein at least one fragrance having a molecular weight between 95 and 225 g / mol is added to the composition or product.

[0040] Preferably, the at least one fragrance is added in an amount of 0.01 to 10% by weight, based on the total weight of the consumer product. More preferably, the at least one fragrance is added in an amount of 0.05 to 5% by weight, based on the weight of the consumer product. Even more preferably, the at least one fragrance is added in an amount of 0.05 to 1% by weight, based on the total weight of the consumer product.

[0041] It is further preferred that the composition or product is a consumer product.

[0042] The preferred embodiments and definitions stated above of course also apply to the method according to the invention.

[0043] Another embodiment of the present invention relates to a cat litter comprising at least one fragrance having a molecular weight between 95 and 225 g / mol as a urease inhibitor.

[0044] All of the above preferred embodiments and definitions of course also apply to the cat litter according to the invention.

[0045] Next, embodiments of the present invention are further described. Example

[0046] Screening for Urease Inhibition Urease catalyzes the formation of ammonia which results in a change in pH (alkalinization). Therefore, a pH indicator can be used to monitor the reaction. The enzyme screening assay is described below. The colorimetric assay is performed in a 96-well plate in conjunction with a microplate spectrophotometer using phenol red as a pH-sensitive indicator. Briefly: Substrate urea, fragrance raw materials and urease were mixed in a well and the absorbance change was monitored at 560 nm for 1 hour. The resulting absorbance curve was compared with an untreated sample (negative control, without inhibitor) and a sample containing a commercial NBPT inhibitor (positive control). Table 1: Well Composition *PBS buffer component concentration: NaCl 0.14 M; KCl, 0.003 M; Na2HPO4, 0.01 M; KH2PO4 0.002 M. The buffer concentrate was adjusted to pH 7.4 with HCl aqueous solution. The reaction rate is given by the color change (absorbance at Δ560 nm) over time: The inhibitory effect is calculated as follows:

[0047] Identification of positive results Typical results of the screening assay are represented in Figure 1. The corresponding calculations are shown in Table 2. In this case, the fragrance raw material (green trace) showed significant inhibition of urease. Table 2: Screening test results

[0048] Positive results A total of 29 highly active compounds were identified through in vitro screening. Interestingly, they share common structural features, such as molecular weights ranging from 95 to 225 g / mol, α,β-unsaturated carbonyl compounds (e.g., damascenes and ionones), a range of β-unsaturated alcohols, and γ-unsaturated esters.

[0049] Application in cat litter The effectiveness of reducing ammonia formation in cat litter was tested using different scent raw materials as shown in the table below (Table 3). Briefly, cat litters were coated with active substances at a final concentration of 0.1% (w / w) relative to dry litter material. In glass bottles with a total volume of 5 liters, cat litters were treated with artificial cat urine, which consisted of a saline solution containing urea and urease. Ammonia production was measured over 5 days by headspace sampling using an ammonia sensitive detector. Table 3: Different fragrances tested in cat litter The results confirmed the urease inhibition effect of the fragrance raw materials, with all tested fragrances showing relatively less ammonia formation compared to the negative (untreated) control. The results are also shown in Figure 2.

Claims

1. Use of at least one fragrance having a molecular weight of 95 to 225 g / mol as a urease inhibitor.

2. The use according to claim 1, wherein the at least one fragrance is not present in an amount sufficient to impart an inherent odor to the composition or product when added thereto.

3. The use according to claim 1 and / or 2, wherein the at least one fragrance is selected from the group consisting of cis-1-(1-ethoxyethoxy)-3-hexene (geraniol acetal), 3,7-dimethyl-2,6-octadien-1-ol (mixed or separated isomers; geraniol), trans-2-hexenol, cis-3-hexenol, trans-2-hexenal, 3,7-dimethyloct-2,6-dienal (Citral FF), cis-3-hexenyl butyrate, (E)-1-(2,6,6-trimethyl-1-cyclohexa-1,3-dienyl)but-2-ene-1-one (Damascenone total), (E)-1-(2,6,6-trimethyl-1-cyclohex-2-enyl)but-2-ene-1-one (Damascone total). alpha), cis-3-hexenyl propionate, cis-3-hexenyl acetate, cis-3-hexenyl hexanoate, cis-3-hexenyl isovalerate, cis-3-hexenyl isobutyrate, (2E)-3-phenylprop-2-en-1-ol (cinnamyl alcohol), α-methylcinnamaldehyde, cis-3-hexenyl salicylate, 4-hydroxy-2,5-dimethyl-3-furanone (Furaneol), methylcyclopentenolone-3,2,2, methylethylhydroxyfuranone, 2-ethoxy-4-methylphenol (Ultravanil), 2-methoxyphenol (guaiacol), 2-methoxy-4-(prop-2-en-1-yl)phenol (eugenol), 3-(1,3-benzodiphenylamine) Helional, Furaminton / Tonkalactone TM ), (2Z)-3,7-dimethylocta-2,6-dien-1-ol (Nerol 900), 2,6-nonadien-1-ol, methylionone α, methylionone γ, or a mixture thereof.

4. The method according to claim 1, wherein the at least one fragrance is selected from the group consisting of cis-3-hexenyl salicylate, cis-1-(1-ethoxyethoxy)-3-hexene (leaf alcohol acetal), trans-2-hexenal, methylethylhydroxyfuranone, cis-3-hexenyl butyrate or mixtures thereof.

5. Use according to at least one of the preceding claims, wherein the at least one fragrance is selected from the group consisting of trans-2-hexenal and / or methylethylhydroxyfuranone.

6. Use according to at least one of the preceding claims, wherein the at least one fragrance is chosen from trans-2-hexenal.

7. Use according to at least one of the preceding claims, wherein the at least one fragrance when added to a composition or product is present in an amount of 0.01 to 10% by weight, based on the total weight of the composition or product.

8. A consumer product containing (a) a fragrance composition comprising at least one fragrance having a molecular weight between 95 and 225 g / mol as a urease inhibitor; and (b) at least one ammonia precursor.

9. The consumable product according to claim 8, wherein the consumable product does not contain any other urease inhibitors.

10. The consumer product according to claim 8 and / or 9, wherein the at least one fragrance is present in an amount of 0.01 to 10% by weight, based on the total weight of the consumer product.

11. The consumer product according to claim 8 and / or 9, wherein the at least one fragrance is present in an amount of 0.05 to 1 wt. %, based on the total weight of the consumer product.

12. The consumer product according to claims 8-11, wherein the ratio of the at least one fragrance having a molecular weight between 95 and 225 g / mol to the at least one ammonia precursor is from 1:1 to 1:

5.

13. A method of inhibiting urease activity in a composition or product, wherein at least one fragrance having a molecular weight between 95 and 225 g / mol is added to the composition or product.

14. The method of claim 13, wherein the at least one fragrance is added in an amount of 0.01 to 10 wt. %, based on the total weight of the composition or product.

15. A cat litter comprising at least one fragrance having a molecular weight between 95 and 225 g / mol as a urease inhibitor.

Citation Information

Patent Citations

  • Process for neutralizing unpleasant odours of animal excreta

    EP0247946A1

  • Perfume compositions

    GB0615580D0

  • Environmentally-Friendly Animal Litter

    US20110061598A1